Search - tctmd.com

Displaying 1 - 20 of 365

Sort: Relevancy | Date

News Daily News

Periprocedural MI Signals Worse Outcomes in Stented NSTE ACS Patients: MATRIX

Michael O'Riordan

January 15, 2026

News Daily News

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Yael L. Maxwell

December 29, 2025

News Conference News AHA 2025

Lower Mortality With Complete Revascularization in Acute MI Patients With MVD

Michael O'Riordan

November 12, 2025

News Conference News TCT 2025

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

Yael L. Maxwell

November 07, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2025

Caitlin E. Cox

November 03, 2025

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

News Conference News TCT 2025

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

L.A. McKeown

October 27, 2025

News Conference News TCT 2025

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

Michael O'Riordan

October 26, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News ESC 2025

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

Michael O'Riordan

August 31, 2025

News Daily News

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

L.A. McKeown

August 12, 2025

Presentation TCT India 2025

Understanding the etiology and imaging diagnosis of stent failure – acute vs late, morphology, and more

Presenter: Ramesh Daggubati

July 25, 2025

News Industry News

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

June 12, 2025

News Conference News EuroPCR 2025

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

Michael O'Riordan

May 20, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

Michael O'Riordan

March 26, 2025

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

L.A. McKeown

March 10, 2025

News Daily News

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Todd Neale

December 20, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

News Conference News TCT 2024

DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF

Caitlin E. Cox

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

Advertisement

Periprocedural MI Signals Worse Outcomes in Stented NSTE ACS Patients: MATRIX

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Lower Mortality With Complete Revascularization in Acute MI Patients With MVD

At 3 Years, DCBs Still Less Safe Than DES in De Novo CAD: REC-CAGEFREE I

TCTMD’s Top 10 Most Popular Stories for October 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

Sirolimus-Coated Balloon Meets Mark in De Novo Lesions and ISR: SELUTION

What’s Going to Be Hot at TCT 2025

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

Coronary DCB Works Well in Multilayer In-Stent Restenosis: AGENT IDE Subanalysis

Understanding the etiology and imaging diagnosis of stent failure – acute vs late, morphology, and more

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

Complete Revascularization in STEMI Still Superior at 10 Years: DANAMI-3-PRIMULTI

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

BMJ Investigation Revives Questions About PLATO, Ticagrelor

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content